Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

A pathophysiological view of primary headaches.

L Edvinsson1

  • 1Department of Internal Medicine, University Hospital, S-221 85 Lund, Sweden.

Functional Neurology
|February 24, 2001
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Origin and Co-localization of nitric oxide synthase, CGRP, PACAP, and VIP in the cerebral circulation of the rat.

Microscopy research and technique·2001
Same author

Pathophysiology of primary headaches.

Current pain and headache reports·2001
Same author

4991W93 inhibits release of calcitonin gene-related peptide in the cat but only at doses with 5HT(1B/1D) receptor agonist activity?

Neuropharmacology·2001
Same author

Characterisation of the effects of a non-peptide CGRP receptor antagonist in SK-N-MC cells and isolated human cerebral arteries.

European journal of pharmacology·2001
Same author

Characterization of CGRP(1) receptors in the guinea pig basilar artery.

European journal of pharmacology·2001
Same author

Enhanced Ca2+-induced contractions and attenuated alpha-adrenoceptor responses in resistance arteries from rats with congestive heart failure.

European journal of heart failure·2001

Primary headaches involve neurotransmitter release, particularly calcitonin gene-related peptide (CGRP) and vasoactive intestinal peptide (VIP). Sumatriptan treatment normalized neuropeptide levels and reduced head pain, indicating sensory and parasympathetic involvement.

Area of Science:

  • Neuroscience
  • Cerebrovascular Research
  • Pain Management

Background:

  • Cerebral circulation is innervated by sympathetic, parasympathetic, and sensory nerves.
  • Neurotransmitters play a role in primary headaches, with a known association between head pain and calcitonin gene-related peptide (CGRP).

Purpose of the Study:

  • To evaluate the role of neurotransmitters in primary headaches.
  • To investigate the association between specific neuropeptides and headache symptoms, including facial autonomic features.

Main Methods:

  • Assessed neuropeptide release in patients experiencing primary headaches.
  • Monitored changes in neuropeptide levels during sumatriptan treatment for headache relief.

Main Results:

Related Experiment Videos

  • Demonstrated a clear association between head pain and the release of calcitonin gene-related peptide (CGRP).
  • Observed release of vasoactive intestinal peptide (VIP) alongside CGRP in cluster and chronic paroxysmal headache, correlating with facial symptoms.
  • Sumatriptan treatment led to the subsidence of head pain and normalization of neuropeptide release.

Conclusions:

  • Sensory and parasympathetic mechanisms are implicated in the pathophysiology of primary headaches.
  • Neuropeptide release, including CGRP and VIP, is a key feature in certain primary headaches.
  • Pharmacological interventions targeting these pathways, like sumatriptan, can effectively manage headache symptoms.